Drug Profile
Edelfosine
Alternative Names: ALP; ET 18 O CH3; ET 18 OME; NSC 324Latest Information Update: 13 Nov 2021
Price :
$50
*
At a glance
- Originator Thorax Hospital
- Developer Calbiochem; Thorax Hospital
- Class Antineoplastics; Ethers; Phospholipids; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Phosphocholine acyltransferase inhibitors; Phospholipase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 Apr 2004 Discontinued - Phase-II for Cancer in Germany (unspecified route)
- 06 Apr 2004 Discontinued - Preclinical for Cancer in France (unspecified route)
- 06 Apr 2004 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)